Quick Answer
UroGen Pharma Ltd. reported Gross Profit of $97.34 million for fiscal year 2025.
UroGen Pharma Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $97.34M | +19.4% |
| 2024 | $81.52M | +11.1% |
| 2023 | $73.35M | +29.4% |
| 2022 | $56.70M | +32.2% |
| 2021 | $42.88M | +297.5% |
| 2020 | $10.79M | +59844.4% |
| 2019 | $18.0K | +102.7% |
| 2018 | -$675.0K | -108.9% |
| 2017 | $7.56M | -56.8% |
| 2016 | $17.50M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.20M | +6.4% | +17.1% |
| June 30, 2025 | $20.66M | +5.3% | +15.3% |
| March 31, 2025 | $17.92M | +5.1% | -21.2% |
| September 30, 2024 | $22.75M | +23.1% | +16.0% |
| June 30, 2024 | $19.62M | +4.9% | +15.0% |
| March 31, 2024 | $17.05M | +14.2% | -7.7% |
| September 30, 2023 | $18.48M | +31.3% | -1.1% |
| June 30, 2023 | $18.70M | +26.7% | +25.2% |
- UroGen Pharma Ltd. showed an increase of +19.4% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, UroGen Pharma Ltd.’s gross profit has grown by 456.2% (from $17.50 million to $97.34 million).
- The most recent figure is from UroGen Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: